| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014815 |
| Receipt No. | R000017225 |
| Official scientific title of the study | A pilot study on the safety and the efficacy of dose escalation in stereotactic body radiotherapy for the lung tumor |
| Date of disclosure of the study information | 2014/09/01 |
| Last modified on | 2018/02/11 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | A pilot study on the safety and the efficacy of dose escalation in stereotactic body radiotherapy for the lung tumor | |
| Title of the study (Brief title) | Dose escalation study in stereotactic body radiotherapy for the lung tumor | |
| Region |
|
|
| Condition | ||
| Condition | Lung Cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety and the efficacy of the dose escalation in stereotactic body radiotherapy for the lung tumor |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | incidence of adverse effect |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Dose escalation in radiotherapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Primary or metastatic lung cancer
A. Primary lung cancer; Tumor size </=5cm, and clinical stage IA or IB B. Metastatic lung cancer; Tumor size </=5cm, two lung lesions or less, and no lesions other than lung 2) Those who are inoperable or who refuse surgery 3) Dose to adjacent organ is not estimated to exceed constraints in pretreatment chest CT 4) Patients' age must be>/=20 years old 5) ECOG performance status must be 0-2 6) Patients can lay on their back holding their arms over the heads, and keep that position at least 30 minutes |
|||
| Key exclusion criteria | 1) previous irradiation around the lesion
2) With active interstitial pneumonia or pulmonary fibrosis 3) With severe diabetic mellitus or collagen disease 4) Women during pregnancy or lactating , or who might be pregnant 5) With psychiatric illness which impede protocol treatment 6) Patients who are considered to be inappropriate for this study by physicians |
|||
| Target sample size | 35 | |||
| Research contact person | |
| Name of lead principal investigator | Yukinori Matsuo |
| Organization | Graduate School of Medicine, Kyoto University |
| Division name | Department of Radiation Oncology and Image-applied Therapy |
| Address | 54 Shogoin Kawaharacho Sakyo-ku, Kyoto |
| TEL | 075-751-3762 |
| ymastuo@kuhp.kyoto-u.ac.jp | |
| Public contact | |
| Name of contact person | Takamasa Mitsuyoshi |
| Organization | Kyoto University Hospital |
| Division name | Department of Radiation Therapy |
| Address | 54 Shogoin Kawaharacho Sakyo-ku, Kyoto |
| TEL | 075-751-3762 |
| Homepage URL | |
| mitsu.t@kuhp.kyoto-u.ac.jp | |
| Sponsor | |
| Institute | Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017225 |